Kohei Karino, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatomyositis | 2 | 2020 | 258 | 1.060 |
Why?
|
| Lupus Erythematosus, Systemic | 5 | 2024 | 2152 | 0.680 |
Why?
|
| Fascia | 1 | 2020 | 140 | 0.670 |
Why?
|
| Thymoma | 1 | 2018 | 188 | 0.560 |
Why?
|
| Microglia | 2 | 2023 | 1357 | 0.560 |
Why?
|
| Thymus Neoplasms | 1 | 2018 | 274 | 0.520 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2020 | 918 | 0.380 |
Why?
|
| Autoantibodies | 1 | 2018 | 2115 | 0.340 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2023 | 153 | 0.260 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 4947 | 0.240 |
Why?
|
| Biological Products | 2 | 2023 | 912 | 0.220 |
Why?
|
| Receptors, CCR6 | 1 | 2021 | 74 | 0.190 |
Why?
|
| Femur Head Necrosis | 1 | 2022 | 132 | 0.190 |
Why?
|
| Propylthiouracil | 1 | 2019 | 68 | 0.160 |
Why?
|
| Cytokines | 3 | 2023 | 7373 | 0.160 |
Why?
|
| Antithyroid Agents | 1 | 2019 | 72 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2018 | 12116 | 0.160 |
Why?
|
| Autoimmunity | 2 | 2024 | 1350 | 0.150 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 283 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2023 | 823 | 0.140 |
Why?
|
| Steroids | 1 | 2022 | 929 | 0.140 |
Why?
|
| Interleukin-17 | 1 | 2022 | 911 | 0.140 |
Why?
|
| Arthritis | 1 | 2022 | 680 | 0.130 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2019 | 225 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2023 | 2481 | 0.110 |
Why?
|
| Bone Marrow | 1 | 2021 | 2909 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2020 | 2624 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2023 | 6634 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 12966 | 0.050 |
Why?
|
| Disease Progression | 1 | 2020 | 13495 | 0.050 |
Why?
|
| Depression | 1 | 2023 | 8132 | 0.050 |
Why?
|
| Succinates | 1 | 2023 | 81 | 0.050 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2022 | 23 | 0.050 |
Why?
|
| TYK2 Kinase | 1 | 2022 | 38 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17878 | 0.050 |
Why?
|
| Carboxypeptidases | 1 | 2022 | 155 | 0.050 |
Why?
|
| Mice | 3 | 2024 | 81368 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 404 | 0.040 |
Why?
|
| Femur Head | 1 | 2022 | 297 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2022 | 577 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 36402 | 0.040 |
Why?
|
| Animals | 4 | 2024 | 168201 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2020 | 583 | 0.040 |
Why?
|
| Chemokines | 1 | 2022 | 954 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2024 | 974 | 0.040 |
Why?
|
| Graves Disease | 1 | 2019 | 238 | 0.040 |
Why?
|
| Japan | 1 | 2020 | 1372 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2022 | 1115 | 0.030 |
Why?
|
| Humans | 9 | 2024 | 760617 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 80566 | 0.030 |
Why?
|
| Male | 4 | 2021 | 360358 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2022 | 1403 | 0.030 |
Why?
|
| China | 1 | 2020 | 2374 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 74115 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3206 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2020 | 2326 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2023 | 3056 | 0.030 |
Why?
|
| Middle Aged | 3 | 2021 | 220584 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 12661 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 4533 | 0.020 |
Why?
|
| Adult | 3 | 2021 | 220969 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 3492 | 0.020 |
Why?
|
| Female | 5 | 2022 | 392148 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 169042 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3794 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2022 | 4935 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2024 | 11514 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 4174 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 12978 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2022 | 3805 | 0.020 |
Why?
|
| Brain | 2 | 2023 | 27101 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2020 | 6561 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 10175 | 0.020 |
Why?
|
| Prevalence | 1 | 2020 | 15689 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18221 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22148 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 15908 | 0.010 |
Why?
|
| Prognosis | 1 | 2022 | 29600 | 0.010 |
Why?
|
| Inflammation | 1 | 2021 | 10760 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59179 | 0.010 |
Why?
|